Clovis Oncology (CLVS)
NASDAQ:CLVS

Clovis Oncology Stock Investors

1,616 Followers
Based on 588,138 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold CLVS
On average, investors allocate 2.44% of their portfolios to CLVS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 588,138 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLVS

0.1%
Last 7
Days
0.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLVS, out of 588,138 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLVS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.12%
$2.41
Increased
0.15%
$1.26
Reduced
0.03%
$0.35
Increased
<0.01%
$1.15
Based on the activity of 11,148 investors who made their portfolios public
The table shows changes in CLVS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLVS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Gilead Sciences
4.33%
+0.34%
+1.04%
$107.56B
Healthcare
Novavax
4.35%
-0.12%
-1.32%
$1.32B
Healthcare
Tilray
5.07%
-0.14%
-0.07%
$2.27B
Basic Materials
JD
4.28%
+0.81%
+3.21%
$83.89B
Consumer Goods
Crispr Therapeutics AG
3.97%
-0.29%
-1.20%
$4.14B
Healthcare
BioNano Genomics
4.53%
-0.47%
-1.00%
$564.16M
Healthcare
Canopy Growth
4.24%
+1.01%
+3.67%
$1.69B
Basic Materials
Bristol Myers
4.12%
+0.04%
-0.07%
$168.03B
Healthcare
General Electric
5.85%
+0.11%
+0.65%
$93.60B
Industrial Goods
Syros Pharmaceuticals
3.64%
-0.84%
-2.96%
$77.47M
Healthcare
Based on the activity of 588,138 active portfolios
Open your Smart Portfolio

CLVS Investor Analysis

CLVS investors under 35

Under 35

9.2%
Last 30 days
Holdings Change
20.1%
of CLVS holders
are under 35
Average Segment Performance
Average P/E Ratio10.33
Beta5.41
Dividend Yield4.31%
CLVS investors between 35–55

Between 35–55

9.4%
Last 30 days
Holdings Change
63.9%
of CLVS holders
are between 35–55
Average Segment Performance
Average P/E Ratio7.35
Beta1.23
Dividend Yield5.14%
CLVS investors over 55

Over 55

4.3%
Last 30 days
Holdings Change
16.0%
of CLVS holders
are over 55
Average Segment Performance
Average P/E Ratio8.58
Beta0.98
Dividend Yield4.40%
Overview of age group and performance of CLVS stock investors
See who invests in CLVS according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
ABMDAbiomed
AGENAgenus
AAgilent
BDXBecton Dickinson
LCTXLineage Cell Therapeutics

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis